Patients with high-risk features undergoing elective PCI and treated with the more-potent antiplatelet agent ticagrelor (Brilinta; AstraZeneca) ... Read More
Gains made in decreasing mortality for ischemic heart disease in the United States over the past two decades have been offset by stagnant or ... Read More
Having a rare genetic disease that you share with about one in 5,000 people could be isolating. But Christian D’Angelo feels like part of a ... Read More
One of the most important things to understand about heart health is that a woman’s needs change over time. Risk factors for heart disease like ... Read More
Hoag’s Jeffrey M. Carlton Heart & Vascular Institute recently expanded its ability to manage and treat complex aortic pathology with the ... Read More